Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease

ClinicalTrials.gov ID: NCT01396213

Public ClinicalTrials.gov record NCT01396213. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 5:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Different Doses of Larazotide Acetate for the Treatment of Celiac Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A randomized, double-blind, placebo-controlled Phase 2B study to evaluate the efficacy and safety of Larazotide Acetate in the treatment of patients with celiac disease who have persistent symptoms despite being on a gluten-free diet.

Study identification

NCT ID
NCT01396213
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
9 Meters Biopharma, Inc.
Industry
Enrollment
342 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2011
Primary completion
Aug 19, 2013
Completion
Aug 19, 2013
Last update posted
Sep 19, 2017

2011 – 2013

United States locations

U.S. sites
56
U.S. states
31
U.S. cities
55
Facility City State ZIP Site status
Not listed Birmingham Alabama 35209
Not listed Mesa Arizona 85206
Not listed Tucson Arizona 85704
Not listed Oceanside California 92056
Not listed Orange California 92868
Not listed San Francisco California 94115
Not listed Santa Monica California 90404
Not listed Walnut Creek California 94598
Not listed Denver Colorado 80222
Not listed Boynton Beach Florida 33426
Not listed Edgewater Florida 32132
Not listed Orlando Florida 32806
Not listed Summerfield Florida 34491
Not listed Marietta Georgia 30067
Not listed Chicago Illinois 60612
Not listed Rockford Illinois 61107
Not listed West Des Moines Iowa 50266
Not listed Wichita Kansas 67207
Not listed Lexington Kentucky 40536
Not listed Louisville Kentucky 40202
Not listed Baltimore Maryland 21229
Not listed Hagerstown Maryland 21742
Not listed Boston Massachusetts 02215
Not listed Chesterfield Michigan 48047
Not listed Wyoming Michigan 49519
Not listed Duluth Minnesota 55805
Not listed Rochester Minnesota 55905
Not listed Jackson Mississippi 39202
Not listed St Louis Missouri 63141
Not listed Missoula Montana 59808
Not listed Las Vegas Nevada 89119
Not listed Marlton New Jersey 08053
Not listed Lake Success New York 11042
Not listed New York New York 10016
Not listed New York New York 10032
Not listed Rochester New York 14618
Not listed Cary North Carolina 27518
Not listed Salisbury North Carolina 28144
Not listed Winston-Salem North Carolina 27103
Not listed Cleveland Ohio 44195
Not listed Mentor Ohio 44060
Not listed Oklahoma City Oklahoma 73160
Not listed Portland Oregon 97210
Not listed Bethlehem Pennsylvania 18017
Not listed Perkasie Pennsylvania 18944
Not listed Philadelphia Pennsylvania 19107
Not listed Pittsburgh Pennsylvania 15243
Not listed Warwick Rhode Island 02886
Not listed Chattanooga Tennessee 37421
Not listed Dallas Texas 75321
Not listed San Antonio Texas 78229
Not listed Salt Lake City Utah 84109
Not listed St. George Utah 84790
Not listed Alexandria Virginia 22304
Not listed Charlottesville Virginia 22911
Not listed Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01396213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2017 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01396213 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →